Premium
P3‐222: In vitro and in vivo study of a magnetic resonance imaging (MRI)/fluorescent contrast agent for detection in Alzheimer's disease
Author(s) -
Ta Robert,
Li Alex X.,
Suchy Mojmir,
Hudson Robert H.E.,
Pasternak Stephen H.,
Bartha Robert
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.1721
Subject(s) - magnetic resonance imaging , in vivo , chemistry , mri contrast agent , gadolinium , nuclear magnetic resonance , dota , fluorescence , nuclear medicine , medicine , radiology , biology , physics , optics , microbiology and biotechnology , organic chemistry
P3-222 IN VITRO AND IN VIVO STUDY OF A MAGNETIC RESONANCE IMAGING (MRI)/FLUORESCENT CONTRAST AGENT FOR DETECTION IN ALZHEIMER’S DISEASE Robert Ta, Alex X. Li, Mojmir Suchy, Robert H. E. Hudson, Stephen H. Pasternak, Robert Bartha, Imaging Research Group, Robarts Research Institute, London, ON, Canada; Department of Medical Biophysics, University of Western Ontario, London, ON, Canada; Department of Chemistry, University of Western Ontario, London, ON, Canada; Molecular Brain Research Group, Robarts Research Institute, London, ON, Canada; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada. Contact e-mail: rta@ imaging.robarts.ca